# Single Dose, Dose-Ranging Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men

> **NCT02754687** · PHASE1 · COMPLETED · sponsor: **Premier Research** · enrollment: 12 (actual)

## Conditions studied

- Healthy Men
- Male Contraception

## Interventions

- **DRUG:** Placebo
- **DRUG:** 11βmethyl nortestosterone dodecylcarbonate

## Key facts

- **NCT ID:** NCT02754687
- **Lead sponsor:** Premier Research
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-14
- **Primary completion:** 2017-01-23
- **Final completion:** 2017-06-05
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-10-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02754687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02754687, "Single Dose, Dose-Ranging Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02754687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*